Data Sheet ABILIFYTM - Medsafe
NZ_DS_Abilify_V2.1_ August2016 - 3 - determined by polydimethylsiloxane-glass bead and equilibrium dialysis assays, respectively) to serum proteins, primarily albumin, in vitro.Aripiprazole did not alter the pharmacokinetics and
Download Data Sheet ABILIFYTM - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Meloxicam - GOV.UK
www.mhra.gov.ukPL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 7 MEDICAL ASSESSMENT Clinical Background Meloxicam is a non-steroidal anti-inflammatory drug of the oxicam family, with anti-
Reflection paper on the dissolution specification for ...
www.ema.europa.euThis reflection paper does not discuss the dissolution tests in three different buffers required as complementary to bioequivalence studies , those tests required in support of biowaiver of strengths or
Reflection paper on the dissolution specification …
www.ema.europa.euconsidered: 80 • Selection of a suitable dissolution medium should be based on the physico- chemical characteristics 81 of the active substance(s) and the intended dose range of the drug pr oduct to be tested.
Mirtazapine 15 mg orodispersible tablets …
www.mhra.gov.ukMirtazapine orodispersible tablets should be taken at the same time each day and are best taken as a single dose before the patient goes to to bed.
frequency. Keeping a headache What is in this leaflet
www.medsafe.govt.nzPage 3of 4 You should NOT take the 10 mg RIZAMELT orodispersible tablet whilst you are taking propranolol. How to take RIZAMELT RIZAMELT orodispersible tablets
Guide de prescription des Neuroleptiques …
www.reseau-pic.infoModalités de prescription du RisperdalConsta LP® : Patients naïfs de rispéridone: établir la tolérance avec de la rispéridone orale avant d'initier le …
SYLOID Silicas - Grace
grace.comgrace.com Ease of Handling and Dispersion The higher density of Syloid® silicas, when compared to many fumed (colloidal) silicas, makes it easier to handle, results in less dust for a cleaner production environment
Référence : CLUD 12 Table pratique de conversion …
www.chu-toulouse.frTable pratique de conversion des opioïdes de palier II et III – CLUD 12 – Version 6 – 1/4
PRINCIPAUX OPIOÏDES FORTS SOURCES …
www.sfap.orgTable pratique d’équiantalgie des opioïdes forts dans la douleur cancéreuse par excès de nociception (ratio calculé à partir du passage par la morphine orale) 1 morphine orale = 1/2 morphine SC = 1/3 morphine IV - Délais action approximatifs de morphine LI : Per os : 40 mn, SC : 20 mn, IV : 10 mn.